dbo:abstract |
RU-16117 is an estrogen medication which was investigated for the potential treatment of symptoms of estrogen deficiency such as hot flashes and osteoporosis in women but was never marketed. It was developed for use by mouth. (en) RU-16117(化学名:11α-甲氧基乙炔雌二醇,与莫克雌醇是11α-差向异构体)是一种雌激素类药物,用于治疗雌激素缺乏综合症,如骨质疏松和潮熱,从未上市销售。 (zh) |
dbo:casNumber |
61665-15-4 |
dbo:class |
dbr:Estrogen_(medication) dbr:Estrogen_ether |
dbo:pubchem |
66408 |
dbo:thumbnail |
wiki-commons:Special:FilePath/RU-16117.svg?width=300 |
dbo:wikiPageID |
56962191 (xsd:integer) |
dbo:wikiPageLength |
9596 (xsd:nonNegativeInteger) |
dbo:wikiPageRevisionID |
1123037367 (xsd:integer) |
dbo:wikiPageWikiLink |
dbr:Progesterone_(medication) dbr:Epimer dbr:Mouse dbr:Methoxy_group dbr:Partial_agonist dbr:Androgen_receptor dbr:Antiestrogen dbr:Hydrocortisone dbr:Uterus dbr:Ligand_(biochemistry) dbc:Abandoned_drugs dbc:Antiestrogens dbc:Diols dbc:Estranes dbc:Ethers dbc:Ethynyl_compounds dbc:Synthetic_estrogens dbr:Estrogen_(medication) dbr:Oral_administration dbr:Steroid dbr:Hot_flash dbr:Progesterone_receptor dbr:Symptom dbr:Agonist dbr:Aldosterone dbr:Estradiol_(medication) dbr:Estrane dbr:Estriol_(medication) dbr:Estrogen_receptor dbr:Ethinylestradiol dbr:Osteoporosis dbr:Glucocorticoid_receptor dbr:Isomer dbr:Testosterone_(medication) dbr:Affinity_(pharmacology) dbr:Tissue_(biology) dbr:Mineralocorticoid_receptor dbr:Moxestrol dbr:Estrogen_ether dbr:Synthetic_compound dbr:Chemical_derivative dbr:Uterotrophic dbr:Estrogen_deficiency |
dbp:c |
21 (xsd:integer) |
dbp:casNumber |
61665 (xsd:integer) |
dbp:chemspiderid |
59782 (xsd:integer) |
dbp:class |
dbr:Estrogen_(medication) dbr:Estrogen_ether |
dbp:h |
26 (xsd:integer) |
dbp:iupacName |
-17 (xsd:integer) |
dbp:o |
3 (xsd:integer) |
dbp:pubchem |
66408 (xsd:integer) |
dbp:routesOfAdministration |
dbr:Oral_administration |
dbp:smiles |
C[C@]12C[C@H]OC (en) |
dbp:stdinchi |
1 (xsd:integer) |
dbp:stdinchikey |
MTMZZIPTQITGCY-QHOCJJNXSA-N (en) |
dbp:synonyms |
11 (xsd:integer) |
dbp:width |
225 (xsd:integer) |
dbp:wikiPageUsesTemplate |
dbt:Abbr dbt:Drugbox dbt:Estrogen_receptor_modulators dbt:Reflist dbt:See_also dbt:Short_description dbt:Abbrlink |
dct:subject |
dbc:Abandoned_drugs dbc:Antiestrogens dbc:Diols dbc:Estranes dbc:Ethers dbc:Ethynyl_compounds dbc:Synthetic_estrogens |
rdf:type |
owl:Thing dul:ChemicalObject dbo:ChemicalSubstance wikidata:Q8386 dbo:Drug |
rdfs:comment |
RU-16117 is an estrogen medication which was investigated for the potential treatment of symptoms of estrogen deficiency such as hot flashes and osteoporosis in women but was never marketed. It was developed for use by mouth. (en) RU-16117(化学名:11α-甲氧基乙炔雌二醇,与莫克雌醇是11α-差向异构体)是一种雌激素类药物,用于治疗雌激素缺乏综合症,如骨质疏松和潮熱,从未上市销售。 (zh) |
rdfs:label |
RU-16117 (en) RU-16117 (zh) |
rdfs:seeAlso |
dbr:List_of_estrogens |
owl:sameAs |
wikidata:RU-16117 dbpedia-zh:RU-16117 https://global.dbpedia.org/id/61umM |
prov:wasDerivedFrom |
wikipedia-en:RU-16117?oldid=1123037367&ns=0 |
foaf:depiction |
wiki-commons:Special:FilePath/RU-16117.svg |
foaf:isPrimaryTopicOf |
wikipedia-en:RU-16117 |
is dbo:wikiPageRedirects of |
dbr:R-16,117 dbr:R-16117 dbr:R16117 dbr:RU-16,117 dbr:RU16117 dbr:RU_16,117 dbr:RU_16117 dbr:R_16,117 dbr:R_16117 dbr:11α-MeO-17α-EE dbr:11α-MeO-EE dbr:11α-Methoxy-17α-ethynylestradiol dbr:11α-Methoxyethinylestradiol dbr:11α-methoxy-17α-ethynylestradiol dbr:11α-methoxyethinylestradiol |
is dbo:wikiPageWikiLink of |
dbr:List_of_estrogens dbr:C21H26O3 dbr:Moxestrol dbr:R-16,117 dbr:R-16117 dbr:R16117 dbr:RU-16,117 dbr:RU16117 dbr:RU_16,117 dbr:RU_16117 dbr:R_16,117 dbr:R_16117 dbr:11α-MeO-17α-EE dbr:11α-MeO-EE dbr:11α-Methoxy-17α-ethynylestradiol dbr:11α-Methoxyethinylestradiol dbr:11α-methoxy-17α-ethynylestradiol dbr:11α-methoxyethinylestradiol |
is foaf:primaryTopic of |
wikipedia-en:RU-16117 |